Neumora Therapeutics, Inc. Common Stock – NASDAQ:NMRA
Neumora Therapeutics, Inc. Common Stock stock price today
$1.65
-9.67
-85.44%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
Neumora Therapeutics, Inc. Common Stock stock price monthly change
+2.53%
month
Neumora Therapeutics, Inc. Common Stock stock price quarterly change
+2.53%
quarter
Neumora Therapeutics, Inc. Common Stock stock price yearly change
-36.70%
year
Neumora Therapeutics, Inc. Common Stock key metrics
Market Cap | 1.73B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -1.61 |
Revenue | N/A |
EBITDA | -272.50M |
Income | -254.02M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNeumora Therapeutics, Inc. Common Stock stock price history
Neumora Therapeutics, Inc. Common Stock stock forecast
Neumora Therapeutics, Inc. Common Stock financial statements
| Jun 2023 | 0 | -38.54M | |
|---|---|---|---|
| Sep 2023 | 0 | -53.02M | |
| Dec 2023 | 0 | -108.73M | |
| Mar 2024 | 0 | -53.72M |
| 2025 | 0 | -270.84M | |
|---|---|---|---|
| 2026 | 36.21M | -323.03M | -892.1% |
Analysts Price target
Financials & Ratios estimates
| 2023-11-01 | -0.36 | -1.14 |
|---|---|---|
| 2024-03-07 | -0.65 | -0.71 |
| 2024-05-07 | -0.35 | -0.34 |
| Jun 2023 | 359952000 | 873.49M | 242.67% |
|---|---|---|---|
| Sep 2023 | 544749000 | 32.05M | 5.88% |
| Dec 2023 | 496195000 | 27.11M | 5.47% |
| Mar 2024 | 450211000 | 25.66M | 5.7% |
| Jun 2023 | -31.02M | 24.07M | 292K |
|---|---|---|---|
| Sep 2023 | -47.77M | 23.81M | 232.02M |
| Dec 2023 | -51.44M | 13.67M | -481K |
| Mar 2024 | -42.95M | -150.00M | 1.84M |
Neumora Therapeutics, Inc. Common Stock alternative data
| Oct 2023 | 110 |
|---|---|
| Nov 2023 | 110 |
| Dec 2023 | 94 |
| Jan 2024 | 94 |
| Feb 2024 | 94 |
| Mar 2024 | 124 |
| Apr 2024 | 124 |
| May 2024 | 124 |
| Jun 2024 | 120 |
| Jul 2024 | 120 |
Neumora Therapeutics, Inc. Common Stock other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2023 | 542618 | 0 |
| Sep 2024 | 0 | 74412 |
| Oct 2024 | 0 | 35611 |
-
What's the price of Neumora Therapeutics, Inc. Common Stock stock today?
One share of Neumora Therapeutics, Inc. Common Stock stock can currently be purchased for approximately $1.65.
-
When is Neumora Therapeutics, Inc. Common Stock's next earnings date?
Unfortunately, Neumora Therapeutics, Inc. Common Stock's (NMRA) next earnings date is currently unknown.
-
Does Neumora Therapeutics, Inc. Common Stock pay dividends?
No, Neumora Therapeutics, Inc. Common Stock does not pay dividends.
-
How much money does Neumora Therapeutics, Inc. Common Stock make?
Neumora Therapeutics, Inc. Common Stock has a market capitalization of 1.73B. Neumora Therapeutics, Inc. Common Stock made a loss 235.93M US dollars in net income (profit) last year or -$0.34 on an earnings per share basis.
-
What is Neumora Therapeutics, Inc. Common Stock's stock symbol?
Neumora Therapeutics, Inc. Common Stock is traded on the NASDAQ under the ticker symbol "NMRA".
-
What is Neumora Therapeutics, Inc. Common Stock's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Neumora Therapeutics, Inc. Common Stock?
Shares of Neumora Therapeutics, Inc. Common Stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Neumora Therapeutics, Inc. Common Stock have?
As Jul 2024, Neumora Therapeutics, Inc. Common Stock employs 120 workers, which is 3% less then previous quarter.
-
When Neumora Therapeutics, Inc. Common Stock went public?
Neumora Therapeutics, Inc. Common Stock is publicly traded company for just a year since IPO on 15 Sep 2023.
-
What is Neumora Therapeutics, Inc. Common Stock's official website?
The official website for Neumora Therapeutics, Inc. Common Stock is neumoratx.com.
-
How can i contact Neumora Therapeutics, Inc. Common Stock?
Neumora Therapeutics, Inc. Common Stock can be reached via phone at 857 760 0900.
Neumora Therapeutics, Inc. Common Stock company profile:
Neumora Therapeutics, Inc. Common Stock
neumoratx.comExchange:
NASDAQ
Full time employees:
124
Industry:
Biotechnology
Sector:
Healthcare
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; and NMRA-266, which is in the phase 1 clinical trial for the treatment of schizophrenia and other neuropsychiatric disorders. In addition, its preclinical phase product includes NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
490 Arsenal Way
Watertown, 02472
Watertown, 02472
CIK: 0001885522
ISIN: US6409791000
CUSIP: 640979100
